Medical Weight Loss Treatment for Ohio Residents
Medically Supervised Weight Loss, Delivered Online
Our providers are licensed by the State Medical Board of Ohio for comprehensive telehealth services statewide.
Whether you're in Columbus, Columbus, or anywhere across Ohio — our board-certified providers are ready to see you.
Medical Weight Loss Treatment in Ohio
Our board-certified providers prescribe FDA-approved and physician-developed weight loss medications including GLP-1 agonists, customized to your health profile and goals.
No office visits required — 100% online consultations
FDA-approved and physician-developed medications
Personalized dosing protocols adjusted to your response
Ongoing provider support and check-ins throughout treatment
Medications shipped directly to your door from licensed pharmacies
Ohio is the heart of it all—manufacturing and medicine, agriculture and innovation, world-class cities and charming small towns. OmniRx Health serves every Buckeye. From the corporate corridors of Columbus to the medical excellence of Cleveland, the cultural richness of Cincinnati to the college towns and farming communities throughout, our telehealth platform fits your Ohio lifestyle. Get expert care without fighting I-71 traffic or waiting weeks for an appointment.
Available Treatments in Ohio
Our board-certified providers in Ohio can prescribe and manage the following treatment options
Semaglutide
Semaglutide is a GLP-1 receptor agonist that reduces appetite and slows gastric emptying, helping patients achieve significant, sustained weight loss. Originally developed for type 2 diabetes management, semaglutide has become one of the most clinically effective weight loss medications available.
Tirzepatide
Tirzepatide is a dual GLP-1 and GIP receptor agonist that produces even greater weight loss than semaglutide alone. It addresses appetite, blood sugar regulation, and metabolic rate through two complementary hormonal pathways for superior outcomes.
Tesofensine
Tesofensine is a triple monoamine reuptake inhibitor that suppresses appetite and boosts metabolism through dopamine, norepinephrine, and serotonin pathways. Originally developed as an anti-Parkinson's agent, it showed exceptional weight loss properties in clinical trials.
Retatrutide
Retatrutide (LY3437943) is a 39-amino acid synthetic peptide and triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Currently in Phase 3 clinical trials (TRIUMPH program), it produced 24.2% average weight loss at 48 weeks in Phase 2 data — the highest weight reduction observed in any peptide trial to date. Listed by OmniRx for research-use only (RUO).
Telehealth Regulations in Ohio
State Licensing
Our providers are licensed by the State Medical Board of Ohio for comprehensive telehealth services statewide.
Telehealth Law
Ohio has telehealth laws that support virtual care delivery while ensuring patient safety and provider accountability.
Pharmacy Access
Ohio's extensive pharmacy network in Columbus, Cleveland, Cincinnati, and throughout the state ensures rapid prescription access.
Insurance Notes
Ohio requires telehealth coverage parity for commercial insurers and has expanded Medicaid virtual care coverage.
Frequently Asked Questions
Common questions about medical weight loss and telehealth access in Ohio
Explore Related Medical Weight Loss Pages
Direct links to specific treatments, other services, and every state we serve.